Find the record behind a claim.

For checking the doctor

State medical-board directory

Use the links supplied by the Federation of State Medical Boards to reach each state and territorial medical board’s doctor licence records.

Use the board’s own record for the final licence answer.

For checking the pharmacy

State pharmacy searches

Each state’s public pharmacy-licence search is linked from a pharmacy-search page maintained by FDA, the US Food and Drug Administration.

The licence itself is what the record confirms; the way a particular medicine is made or supplied is outside that check.

Ask the pharmacy to name the ingredient and show the rule that allows it to make that medicine. Ask the doctor how the medicine fits your health problem.

For approval and human studies

FDA’s substance assessment

FDA’s July 2026 assessment found too little human evidence to establish BPC-157’s safety and benefit for the bowel disease it evaluated.

In the US, medicine reviews are handled by FDA, whose initials stand for Food and Drug Administration. Ask the doctor to explain what its review says about the treatment you are considering.

For the request taken back

FDA’s ingredient table

FDA’s page, marked current on April 22, 2026, lists a request to let pharmacies use BPC-157 that the requesting groups took back. The page gives no date for that withdrawal.

Taking the request back gives no approval or permission to use the ingredient.

For new research

Public study records

ClinicalTrials.gov lists study plans, progress and results when they are posted. As of September 2026, its BPC-157 study for injuries to muscles at the back of the thigh had begun in China. The planned US study after shoulder surgery had not begun, and neither had reported results.

Open a study’s record and check its progress and results sections. A plan alone cannot tell you whether treatment helped anyone.

For the online care process

Medical-board prescribing guidance

The medical-board guidance adopted in May 2026 calls for an actual assessment and a route for patients to raise follow-up questions.

This suggests rules for state boards to use. Doctors must follow the rules of the state where they treat you.